The co-administration of N-acetylcysteine (NAC) and aspirin in patients with bipolar disorder may reduce depressive symptoms, according to study data published in The Journal of Clinical Psychiatry.
The co-administration of N-acetylcysteine (NAC) and aspirin in patients with bipolar disorder may reduce depressive symptoms, according to study data published in The Journal of Clinical Psychiatry.